CompletedNot Applicable

Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer

United States10 participantsStarted 2019-02-19

Plain-language summary

The purpose of this study is to determine if there are markers in plasma that can be used to develop a diagnostic panel for early detection and diagnosis of high grade serous epithelial ovarian cancer.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female * 18 years of age and older * Women with an undiagnosed pelvic mass who need to undergo diagnostic laparoscopic surgery Exclusion Criteria: * Male * Under 18 years of age * Women who can not give informed consent

What they're measuring

Identification of DNA markers using HiSeq Genome Analyzer that can predict Serous Epithelial Ovarian Cancer

Timeframe: 2 years

Trial details

NCT IDNCT03622385

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09-28

View on ClinicalTrials.gov More Epithelial Ovarian Cancer trials